insights_auto
Why is DBV down 2.03%?
Dive Deeperchevron_right
DBV:EPA
DBV Technologies SA
€2.03
arrow_downward
-2.03%(-0.042) 1D
Sep 29, 4:07:24 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
€2.07
High
€2.09
Low
€2.03
Mkt. cap
640.00M
Avg. vol.
1.06M
Volume
482.54K
52-wk high
€4.50
52-wk low
€1.55
EPS
-€0.63
Shares outstanding
314.39M
No. of employees
170
Open
€2.07
High
€2.09
Low
€2.03
Mkt. cap
640.00M
Avg. vol.
1.06M
Volume
482.54K
52-wk high
€4.50
52-wk low
€1.55
EPS
-€0.63
Shares outstanding
314.39M
No. of employees
170
News stories
From web sources and news partners
Ideal Investisseur
·
9 minutes ago
DBV Technologies stock threatens its €2 support level, under selling pressure
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA